Edition:
United States

Carmat SA (ALCAR.PA)

ALCAR.PA on Paris Stock Exchange

23.18EUR
5:11am EDT
Change (% chg)

€0.05 (+0.22%)
Prev Close
€23.13
Open
€23.13
Day's High
€23.20
Day's Low
€23.10
Volume
918
Avg. Vol
4,465
52-wk High
€40.06
52-wk Low
€23.04

Latest Key Developments (Source: Significant Developments)

Stéphane Piat has been appointed CEO of Carmat
Thursday, 1 Sep 2016 01:00am EDT 

Carmat : Stéphane Piat, previously division vice president of Abbott in California, has been appointed CEO of Carmat .Appointment of Stéphane Piat as company`s new Chief Executive Officer effective September 1, 2016.  Full Article

Carmat announces departure of CEO Marcello Conviti
Thursday, 1 Sep 2016 01:00am EDT 

Carmat SA :Carmat announces the departure of CEO Marcello Conviti.  Full Article

Carmat obtains necessary approvals to begin PIVOTAL study in France
Wednesday, 13 Jul 2016 02:07am EDT 

Carmat SA : Carmat has obtained the necessary approvals to begin the PIVOTAL study in France .Simultaneously, Carmat has begun procedures to obtain approval to implant its artificial heart in other European countries.  Full Article

Carmat begins CE Certification process for its artificial heart
Thursday, 23 Jun 2016 12:00pm EDT 

Carmat SA : Carmat has begun, with Dekra, the ce certification process for its bioprosthetic artificial heart .Assessment aims to ensure its compliance with European regulatory requirements.  Full Article

Carmat completes its EUR 50.0 mln reserved capital increase
Wednesday, 27 Apr 2016 02:08am EDT 

Carmat SA:Carmat completes its 50.0 million euros reserved capital increase.1,349,159 new shares issued should be listed on Alternext Paris market from April 28.  Full Article

Carmat announces 50 mln euro equity financing
Friday, 26 Feb 2016 08:37am EST 

Carmat SA:Announces capital increase plan for minimum of 50.0 million euros.Pool of strategic investors will fully subscribe 50.0 million euro equity financing.Airbus is taking 22.0 pct; Cornovum (Bpifrance & french state) is taking 34.0 pct.  Full Article

Carmat updates on feasibility study of bioprosthetic artificial heart
Tuesday, 22 Dec 2015 12:38pm EST 

Carmat SA:Says ‍third patient, who was implanted with a Carmat prosthesis on April 8, died on morning of Dec. 18.Says ‍analyses carried out do not show that prosthesis was involved in patient's death.Says is continuing feasibility study.  Full Article

Photo

French implant maker Carmat pins hopes on low energy heart

PARIS Artificial heart maker Carmat is hoping a more energy-efficient implant and the appointment of a production chief can help it overcome recent failures at the French firm.